Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 21, Issue 1, 2002, Pages 79-85

  Sobti, Ranbir C ^a   Parashar, Kamana ^a   Kaur, Raminder ^a   Capalash, Neena ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cervical cancer; HPV; p53 antibodies; p53 protein

Indexed keywords

ANTIBODY; PROTEIN P53; VIRUS DNA;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOGENICITY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0036210501     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v21.i1.80     Document Type: Article

References (38)

1. Use of polymerase chain reaction to study the relationship between human papillomavirus infection and cervical cancer
2. Human papillomaviruses in the pathogenesis of anogenital cancer
3. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undermined significance
4. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction
5. Oncogenes and tumor suppressor genes: New biochemical tests
6. p53 mutations in human cancers
7. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
8. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators
9. Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP 70 complexes
10. Detection and typing of human papillomavirus infection of the uterine cervix by dot blot hybridization: Comparison of scrapes and biopsies
11. Calcium-dependent bacteriophage DNA infection
12. Analysis by polymerase chain reaction of the physical status of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions
13. Incidence of human papillomavirus in patients with invasive cervical carcinoma
14. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
15. HPV16 DNA in cervical cancers and in lymphnodes of cervical cancer patients: A diagnostic marker for early metastases?
16. Detection of DNA and E7 transcripts of human papillomavirus type 16, 18, 31 and 33, TGFB and GM-CSF transcripts in cervical cancers and precancers
17. Human papillomavirus genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities
18. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
19. Human papillomavirus infection is transient in young women: A population-based cohort study
20. Persistence of type-specific human papillomavirus infection among cytologically normal women
21. Epidemiological evidence for age dependent regression of preinvasive cervical cancer
22. Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease
23. Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions
24. Detection of serum p53 protein in lung cancer patients
25. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
26. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry
27. Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer
28. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
29. Clonal p53 mutation in primary cervical cancer: Association with human-papillomavirusnegative tumors
30. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins
31. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers
32. Serum p53 antibodies as early markers of lung cancer
33. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers
34. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot
35. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
36. Heat shock protein in immune response to cancer. The fourth paradigm